Google’s parent company funds start-up to ‘edit genes to protect against heart disease’
Google’s parent company, Alphabet, is now pouring funds into a start-up wants to gene-edit heart disease out of existence using a one-time injection. Verve Therapeutics hopes to leverage its CEO’s discovery of a gene he believes is linked to lower heart disease risks to ‘fix’ the DNA of people at high risk of heart disease. … Read more